Amavita has started using AISAP’s AI-powered POCUS diagnostic in community settings for aortic stenosis screening.
The company is currently preparing for Phase III trials to further assess the efficacy and safety of the agent in identifying active inflammation in individuals with Crohn's disease. Credit: ...